T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers

Journal: Nature Medicine

Published: 2020-05-11

DOI: 10.1038/s41591-020-0858-8

Affiliations: 22

Authors: 34

Go to article
Institutions Share
Woodruff Health Sciences Center (WHSC), Emory University, United States of America (USA) 0.35
Stanford Medicine, United States of America (USA) 0.10
University of Minnesota (UMN), United States of America (USA) 0.09
Duke University Health System, United States of America (USA) 0.06
LSU Health Sciences Center New Orleans (LSUHSC-NO), United States of America (USA) 0.06
Cornell University, United States of America (USA) 0.06
BioLegend, Inc., United States of America (USA) 0.06
University of California, San Diego (UC San Diego), United States of America (USA) 0.06
3M Company, United States of America (USA) 0.06
Stanford University, United States of America (USA) 0.05
University of Pennsylvania Health System (UPHS), United States of America (USA) 0.03
Western University (UWO), Canada 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER